Doll therapy for a memory care group means setting up a small collection of soft-bodied baby dolls, a quiet space, and a clear staff protocol so residents with dementia can hold, rock, or "care for" a doll during moments of agitation or restlessness. It works best as a planned activity with written consent from family, not an improvised prop handed out mid-crisis. The approach has real evidence behind it, but the details of setup matter more than the general idea. A doll left in a group room without guidelines can create confusion between residents, or spark a family objection that a properly introduced program would have avoided.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- Does Doll Therapy Actually Reduce Agitation?
- Why a Doll Calms Someone With Dementia
- Setup and Supplies for a Group Program
- Handling Family Objections and Dignity Concerns
- Where the Evidence Still Falls Short
- Frequently Asked Questions
Does Doll Therapy Actually Reduce Agitation?
Yes, and the effect size is larger than most non-drug dementia interventions report. A 2023 systematic review and meta-analysis covering five major databases found doll therapy produced a large reduction in agitation among nursing-home residents with dementia, with additional improvements in apathy, irritability, wandering, anxiety, and depression, according to a 2023 meta-analysis in Archives of Gerontology and Geriatrics. That finding is backed by controlled trials, not just observational reports.
A randomized controlled trial tested doll therapy as a first-line, non-drug treatment for behavioral and psychological symptoms of dementia and found reduced challenging behaviors compared with usual care, per a 2021 trial published via PMC. A separate single-blind randomized trial focused on women with dementia in nursing homes reported the same pattern versus a control group, according to a 2022 trial in PMC. The clinical rationale is scale: agitation is the third most common neuropsychiatric symptom in dementia, affecting roughly 30% of people with dementia overall and up to about 80% of residents in nursing facilities, per Cleveland Clinic Consult QD. That prevalence is why facilities look for options beyond medication in the first place.
Why a Doll Calms Someone With Dementia
The leading explanation is attachment theory, not simple distraction. Dementia can reactivate lifelong attachment-seeking behavior — the instinct to seek protection and physical closeness when feeling vulnerable — and a doll can satisfy that through caregiving-type interaction, such as holding, rocking, or dressing it, according to a pilot study on doll therapy and attachment published in PMC. This matters for how a group leader introduces the doll.
Presenting it as a task ("hold this") works less well than letting a resident discover a caregiving role on their own — checking on the doll, tucking it in, or comforting it — since the mechanism is about restoring a felt sense of purpose and closeness, not occupying idle hands. Earlier research reached similar conclusions from a different angle. A 2016 systematic review found preliminary evidence that doll therapy builds a therapeutic bond, promotes social behavior, provides sensory stimulation, and improves communication, while cautioning that overall empirical support was still limited at that time, per a 2016 review. Newer research, including the 2021 and 2022 controlled trials above, has since added stronger evidence on top of that earlier signal.
Setup and Supplies for a Group Program
A group program needs more than a bin of dolls. Based on the documented evidence and the gaps researchers have flagged, a workable setup includes: Despite the strong 2023 meta-analysis results, a 2024 scoping review of therapeutic doll interventions in care homes concluded that the evidence base, while growing, still lacks large, methodologically rigorous clinical trials, and it called for formal guidelines covering doll selection, handling and storage protocols, staff training, and consent procedures before wider rollout, according to a 2024 scoping review in the journal Geriatrics. A program built around the checklist above follows that guidance directly rather than waiting for a finished standard.
- **Soft-bodied dolls, not hard plastic.** Findings presented at the American Psychiatric Nurses Association's 39th Annual Conference reported that soft-bodied baby dolls used with agitated dementia patients were associated with reduced agitation behaviors and visible changes in demeanor, per coverage of APNA 2025 in Clinical Advisor.
- **A few dolls, not one shared doll.** Sharing invites conflict between residents who each form an attachment; a small individual supply avoids that.
- **A dedicated storage and handling routine.** Dolls should be stored consistently and handled the same way by every staff member, so the object stays recognizable and reassuring session to session.
- **A quiet space for one-on-one moments.** Group settings work for some residents, but agitation often needs a lower-stimulation space to start.
- **A written introduction protocol.** Staff need a consistent way to offer the doll — timing, phrasing, and what to do if a resident declines it.
Handling Family Objections and Dignity Concerns
Doll therapy is ethically contested, and a memory care group should expect pushback before it happens, not after. Ethicists and dementia-care researchers flag the practice on grounds of potential infantilization and patient dignity, but also note that objecting family members are often reacting to their own embarrassment rather than to any harm the resident experiences.
Current guidance calls for explaining the therapeutic goals to families and obtaining their approval before starting, per ethics analyses summarized by DementiaHub.SG. In practice, that means a short conversation before the first session: what the doll is for, what improvement looks like (less agitation, calmer demeanor), and that staff will not correct or "reality orient" the resident if they refer to the doll as a real baby. Documenting that consent conversation protects both the resident's dignity and the program itself if a family member raises concerns later.
Where the Evidence Still Falls Short
The research supports doll therapy's effect on agitation more strongly than it supports any specific product, protocol, or dosage. None of the trials above specify how many dolls per resident, how long sessions should run, or how to phase a doll out if a resident's needs change — those operational questions are left to each facility's judgment, which is exactly why the 2024 scoping review called for formal guidelines rather than treating the intervention as fully standardized.
Commercial development has moved faster than the research standards have. An Alzheimer's Society accelerator-partnership funding award supported turning academic doll-therapy design research into a manufactured, commercially available product for people with dementia, signaling movement from clinical study toward practical, supply-ready implementation — though this item is directionally sourced rather than confirmed against a single primary Alzheimer's Society page, and a group should verify current product details directly with any supplier before purchasing. Until formal guidelines exist, the safest approach is to pair any commercial doll purchase with the consent, storage, and introduction protocol described above, rather than assuming the product itself carries a validated standard of use.
Frequently Asked Questions
Should every resident in a memory care group get a doll?
No. The trials measured effects in residents already showing agitation or challenging behaviors; a doll offered without that need can confuse a resident who does not want or benefit from it.
What if a family member says the doll is demeaning?
Ethics guidance recommends explaining the therapeutic goal directly and getting family approval before starting, since objections often stem from the family's own discomfort rather than harm to the resident, per DementiaHub.SG.
Is doll therapy meant to replace medication for agitation?
The 2021 trial tested it as a first-line, non-drug option, meaning it is meant to be tried before or alongside medication decisions, not as an automatic replacement for prescribed treatment, per the PMC-published trial.
